Anew Health, a Hong Kong-based pain management and health services provider, filed on Friday with the SEC to raise up to $20 million in an initial public offering.
The company plans to raise $20 million by offering 5 million shares at $4. At the proposed price, Anew Health would command a market value of $220 million.
Under its ANKH brand, Anew Health offers a broad range of non-surgical, non-invasive, and non-pharmacological pain management treatment and therapies, functional enhancement therapies, and health products. The company provides its pain management and function enhancement services via three service centers in Hong Kong.
Anew Health was founded in 2007 and booked $41 million in revenue for the 12 months ended September 30, 2024. It plans to list on the Nasdaq under the symbol AVG. The company filed confidentially on June 21, 2024. D. Boral Capital is the sole bookrunner on the deal.
